Navigation Links
Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies
Date:11/19/2009

DAYTON, Ohio, Nov. 19 /PRNewswire/ -- Riverain Medical announced today that the company will be partnering with leading Canadian medical imaging distributor Christie Group to offer SoftView Enhanced Chest Imaging and OnGuard Chest Xray CAD. The exclusive agreement will bring Dayton, Ohio based Riverain Medical's products to the Canadian market through Christie Group's established and reputable sales channel.

SoftView Enhanced Chest Imaging increases the clarity of digital chest X-ray images by suppressing bone and providing a soft tissue image for more confident image interpretations. This practical enterprise-wide solution uses existing X-ray equipment, providing a soft tissue image for digital chest X-rays.*

OnGuard Chest X-ray CAD identifies solitary pulmonary nodules on a chest X-ray, which could represent early-stage lung cancer. With universal PACS connectivity and seamless integration into the radiologist's existing workstation, OnGuard is a quick and easy to use tool in the fight against lung cancer. A recent study demonstrates that OnGuard can detect almost 50% of lung cancers that were missed in the initial interpretation.+

"Our technologies turn a century-old medical procedure, the chest X-ray, into a more precise, versatile solution for detecting medical conditions," said Diane Hirakawa, CEO and Chairman of Riverain Medical. "Riverain Medical is making a difference in the healthcare industry. We create solutions that are practical, safe and improve the detection of diseases early, when it really counts."

"Christie is really proud to partner with Riverain today," says Andre Dugas, COO of Christie Group. "This novel bone removal and CAD solution bolsters and valuably complements our broad radiology product portfolio. It fits on any PACS, with any radiographic chest image from any source, providing a global, cost effective tool for lung disease detection and evaluation."

About Riverain Medical

Dayton, Ohio based Riverain Medical is an industry leader and technology innovator, providing physicians with tools to assist them in image interpretation. With a focus on early detection, Riverain continues research and development efforts to advance imaging technologies in new and innovative applications.

Riverain is dedicated to saving lives by improving the detection and diagnosis of diseases and other clinical conditions. The company's researchers and clinical partnerships are a vital part of this mission. Cleveland Clinic, Georgetown University Medical Center, University of Chicago, University Hospitals of Cleveland and Amsterdam Medical Center collaborate with Riverain to ensure that products are high-quality and clinically effective technologies.

About Christie Group

Christie Group develops, distributes, integrates and supports technological products and solutions that improve performance of Canadian health care institutions in the areas of medical imaging and healthcare management solutions.

Christie's professionals across the country help hospitals and clinics to optimize their imaging rooms and to enhance their performance in terms of screening, diagnosis, and management. Christie delivers their customers extensive technical and clinical support for improving workflows, optimizing use of imaging technology, thereby helping them delivering the best care possible to the ones that count on them.

* SoftView is available in Canada, EU & Australia

+ White, C., Flukinger, T., Jeudy, J., Chen, J. (2009). Use of a Computer-aided Detection System to Detect Missed Lung Cancer at Chest Radiography. Radiology. 252.

SOURCE Riverain Medical


'/>"/>
SOURCE Riverain Medical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... The narrative in “ Signal 8: An Australian Paramedic’s ... of his paramedic experiences. Schanssema describes the tragedies he saw, as well as his ... them. , Schanssema, initially unsure of the career path he wanted to take, found ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating ... Me Beyond What You See” body image mannequin art competition. Selected from 15 submissions ... and the winner revealed at the 31st annual iaedp Symposium, March 22 – 26 ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... , ... The 89th Academy Awards will be celebrated this weekend, which means ... Bunkum Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the ... Center for American Progress (CAP), for its report, Lessons From State Performance on NAEP: ...
(Date:2/23/2017)... ... ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will be appearing ... which will begin airing on February 24, 2017. The show chronicles the weight loss ... television series, “Here Comes Honey Boo Boo.” The earlier series from TLC lasted for ...
Breaking Medicine News(10 mins):